Category Archives: SPOTLIGHT

Etiology of esophageal cancer – genetic factors

Etiology of esophageal cancer – genetic factors, it has long been noted that the phenomenon of familial aggregation of esophageal cancer, which makes people think of genetic factors in the pathogenesis of esophageal cancer may occupy a certain position. It was observed that family members of the high incidence of chromosomal aberrations was significantly higher… Read More »

Factors in the etiology of esophageal cancer and other

Etiology of esophageal cancer, and other factors 1. Gender and Age The incidence of this disease and gender, age. Census data show that the ratio of men and women suffering from esophageal cancer in China is about 1.3:1 – 2 .7:1, the United States is about 2:1.4 door, but in the high incidence of disease… Read More »

Preparation before surgery of esophageal cancer

Thoracic esophageal cancer surgery is more invasive surgery, because to be involved thoracic and abdominal cavities of two surgical procedures, so the impact of respiratory and circulatory system are more serious than other chest surgery. Therefore, preoperative esophageal cancer patients should be more careful and meticulous preparation.Esophageal cancer surgery 1. Detailed history and comprehensive physical… Read More »

Esophageal and gastric cardia in the exploration and tumor resection

Thoracic esophageal cancer after surgical exploration should be the first foreign invasion of tumor extent, lymph node metastasis, to determine whether radical resection of tumor. Tumor and surrounding tissue was "frozen state" who, with no removal of hope that the agreement should be considered a shortcut to do or give up surgery.Esophageal and gastric cardia… Read More »

Evaluation of esophageal cancer drugs fluorouracil

Fluorouracil (5-FU) are widely used to treat breast cancer , gastrointestinal cancer, head and neck cancer and other malignant tumors, the first choice for the treatment of colorectal cancer drug. Now that's more effective than continuous intravenous injection.FU evaluation, summarized a large number of clinical trials the following conclusions can be drawn: CF plus 5-FU… Read More »

Esophageal cancer chemotherapy drug doxorubicin Notes

Note doxorubicin (1) extravasation can cause tissue necrosis after, it must determine venous patency before administration. (2) shall not exceed total 450–550mg/ml, avoid serious cardiac toxicity. Note doxorubicin (3) during the period of mediastinal or thoracic radiotherapy should not be using this in the past received mediastinal radiation therapy should be reduction. (4) treatment should… Read More »

Esophageal cancer chemotherapy drug cis evaluation of uranium

Soon the evaluation of uranium, uranium along the most commonly used in clinical anticancer drug, and its broad spectrum anti-tumor, bone marrow suppression lighter, using a variety of tumors combined regimen has a good effect. Renal toxicity in recent years to resolve and gastrointestinal reactions, based on a number of refractory tumors and be effective… Read More »

Esophageal cancer chemotherapy drug carboplatin Notes

Esophageal cancer chemotherapy drug carboplatin Notes Carboplatin Notes (1) medication should be closely observed during the blood and liver and kidney function. (2) The drug is stable dissolved in 5% GS, 8h run out. Carboplatin Note (3) significant bone marrow suppression and renal insufficiency were hanged. (4) during pregnancy.Note carboplatin (5) infusion should avoid direct… Read More »

Esophageal cancer chemotherapy drug oxaliplatin Notes

Esophageal cancer chemotherapy drug oxaliplatin Note Oxaliplatin Note (1) prohibits the drug diluted with saline. (2) prohibit the use of ice water and cold rinse. Oxaliplatin Note (3) the prohibition or alkaline solution with the basic compatibility of drug infusion.Note oxaliplatin (4) in the preparation of infusion to avoid contact with chemicals and aluminum products.

Esophageal cancer chemotherapy drug ifosfamide Notes

Esophageal cancer chemotherapy drug ifosfamide Note Ifosfamide Note (1) liver, kidney dysfunction or only one kidney patients should be used with caution or disabled. Ifosfamide Note (2) hydration, diuretic, and application of Mesna is to reduce or eliminate hemorrhagic cystitis effective measures. Ifosfamide Note (3) to minimize the sedatives, analgesics, anti-adhesive drugs and anesthetics group… Read More »